Cleveland Clinic Revives Heart-Disease Test Patent Row
By Dani Kass (February 22, 2017, 6:38 PM EST) -- The Cleveland Clinic Foundation on Tuesday continued its push to block True Health Diagnostics LLC from using a test for cardiovascular disease that the foundation discovered, claiming in Virginia federal court that True Health infringed one of its patents.
The complaint alleges that True Health is infringing U.S. Patent No. 9,575,065 — which is owned by the foundation and licensed exclusively to co-plaintiff Cleveland HeartLab Inc. — by using myeloperoxidase testing, which assesses cardiovascular disease risk by analyzing blood vessel inflammation.
The suit comes almost exactly a year after an Ohio federal court dismissed a similar suit that Cleveland HeartLab brought against...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!